Financials · BRKR

Bruker Corporation (BRKR) financials

For the twelve months ended Sep 30, 2026, Bruker Corporation reported $3.51B of revenue and -$123.40M of net income.

Revenue, TTM
$3.51B
Revenue growth, YoY
+2.2%
Net income, TTM
-$123.40M
Net margin
-3.5%
Free cash flow, TTM
$244.70M
EPS, diluted, TTM
-$1.10
Cash
$119.70M
Total debt
$1.70B
P/S
2.45
Market cap
$8.62B
Annual revenue$3.44B
FY2016FY2025
Annual net income-$8.60M
FY2016FY2025
Annual free cash flow$43.30M
FY2016FY2025

BRKR revenue and earnings growth

BRKR revenueQ3 2026$874.00M

Quarter YoY
+1.6%
QoQ
+4.2%
FY YoY
+2.1%
5Y CAGR
+11.6%
10Y CAGR
+7.8%

BRKR revenue was $874.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 1.6% from a year earlier and up 4.2% from the prior quarter. For the full fiscal 2025 it was $3.44B, up 2.1% from fiscal 2024. Compound annual growth was +11.6% over 5 years and +7.8% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

BRKR net incomeQ3 2026-$111.80M

BRKR net income was -$111.80M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$59.60M a year earlier. For the full fiscal 2025 it was -$8.60M, compared with $113.10M in fiscal 2024.

BRKR EPSQ3 2026-$0.81

BRKR diluted EPS was -$0.81 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.41 a year earlier. For the full fiscal 2025 it was -$0.15, compared with $0.76 in fiscal 2024.

BRKR free cash flowQ3 2026$96.70M

FY YoY
-68.2%
5Y CAGR
-28.7%
10Y CAGR
-14.0%

BRKR free cash flow was $96.70M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$54.10M a year earlier. For the full fiscal 2025 it was $43.30M, down 68.2% from fiscal 2024. Compound annual growth was -28.7% over 5 years and -14.0% over 10 years. It rose in 4 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue$3.44B$3.37B$2.96B$2.53B$2.42B$1.99B$2.07B$1.90B$1.77B$1.61B
Cost of revenue$1.86B$1.72B$1.45B$1.23B$1.21B$1.05B$1.08B$995.60M$949.90M$866.00M
Gross profit$1.58B$1.65B$1.51B$1.31B$1.21B$939.80M$995.30M$900.00M$816.00M$745.30M
Research and development$395.20M$376.50M$294.80M$235.90M$220.80M$198.00M$187.70M$173.40M$161.60M$147.90M
Selling, general and admin$946.50M$893.80M$729.40M$607.40M$561.20M$468.60M$500.20M$444.70M$415.20M$389.80M
Operating income$68.20M$253.10M$436.90M$432.70M$413.30M$248.30M$300.90M$262.40M$219.50M$181.80M
Interest expense$60.30M$47.90M$16.40M$16.10M$14.30M$14.40M$16.00M$12.60M$15.40M$13.20M
Pre-tax income$22.00M$206.90M$544.20M$413.90M$393.60M$225.80M$280.40M$244.70M$197.80M$177.60M
Income tax$29.30M$91.40M$117.70M$116.40M$113.00M$64.40M$82.40M$63.70M$117.50M$23.10M
Net income-$8.60M$113.10M$427.20M$296.60M$277.10M$157.80M$197.20M$179.70M$78.60M$153.60M
EPS, basic-$0.15$0.76$2.92$2.00$1.83$1.03$1.27$1.15$0.50$0.95
EPS, diluted-$0.15$0.76$2.90$1.99$1.81$1.02$1.26$1.14$0.49$0.95
Diluted shares151.8M149.5M147.2M149.4152.9154.6156.6157.2M159.1M162.2M

Balance sheet

Balance sheet
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Cash and equivalents$298.80M$186.70M$491.60M$648.70M$1.07B$685.50M$681.90M$326.30M$328.90M$345.90M
Short-term investments---$0$100.00M$50.00M$6.60M$0$114.20M-
Receivables$544.90M$565.50M$492.00M$472.70M$416.90M$335.30M$362.20M$357.20M$319.30M$243.90M
Inventory$1.09B$1.07B$968.30M$800.10M$710.10M$692.30M$577.20M$509.60M$486.20M$440.40M
Current assets$2.21B$2.05B$2.16B$2.11B$2.47B$1.93B$1.80B$1.30B$1.36B$1.28B
Goodwill$1.55B$1.51B$582.60M$457.60M$339.50M$320.40M$293.00M$275.70M$169.80M$130.60M
Total assets$6.24B$5.81B$4.25B$3.61B$3.65B$3.05B$2.77B$2.13B$1.95B$1.81B
Current liabilities$1.28B$1.28B$1.20B$914.30M$938.50M$791.90M$645.60M$599.30M$524.50M$524.70M
Long-term debt$1.85B$2.06B$1.16B$1.20B$1.22B$842.30M$812.80M$322.60M$415.60M$391.60M
Total debt$1.85B$2.06B$1.16B$1.20B$1.22B$842.30M$812.80M$322.60M$415.60M$391.60M
Total liabilities$3.73B$3.99B$2.84B$2.48B$2.57B$2.07B$1.85B$1.22B$1.22B$1.12B
Shareholders' equity$2.47B$1.80B$1.39B$1.13B$1.08B$974.30M$917.10M$905.10M$733.50M$693.10M

Cash flow

Cash flow
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Operating cash flow$134.10M$251.30M$350.10M$274.40M$282.40M$332.20M$213.40M$239.70M$154.40M$130.80M
Capital expenditures$90.80M$115.30M$106.90M$129.20M$92.00M$97.20M$73.00M$49.20M$43.70M$37.10M
Free cash flow$43.30M$136.00M$243.20M$145.20M$190.40M$235.00M$140.40M$190.50M$110.70M$93.70M
Investing cash flow-$196.50M-$1.76B-$326.00M-$251.60M-$192.40M-$192.70M-$158.40M-$123.40M-$30.20M-$21.80M
Financing cash flow$135.10M$1.23B-$193.40M-$415.30M$318.70M-$161.60M$300.00M-$112.40M-$159.00M-$27.90M
Dividends paid$22.80M$30.20M$29.40M$29.80M$24.20M$24.60M$25.00M$25.10M$25.40M$25.80M
Share repurchases$10.00M$0$152.30M$263.10M$153.30M$123.20M$142.30M-$152.20M$160.00M
Stock-based compensation$20.20M$25.30M$30.90M$27.70M$17.20M$16.00M$9.60M$11.30M$11.00M$9.40M
Depreciation and amortization$220.30M$183.80M$114.90M$88.80M$89.10M$80.40M$75.60M$64.90M$63.90M$54.30M

Key ratios

Key ratios
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue growth, YoY2.1%13.6%17.1%4.7%21.7%-4.1%9.3%7.3%9.6%-0.8%
Net income growth, YoY--73.5%44.0%7.0%75.6%-20.0%9.7%128.6%-48.8%51.2%
EPS growth, YoY--73.8%-9.9%77.5%-19.0%-132.7%-48.4%58.3%
Gross margin45.9%49.0%51.0%51.6%50.0%47.3%48.0%47.5%46.2%46.3%
Operating margin2.0%7.5%14.7%17.1%17.1%12.5%14.5%13.8%12.4%11.3%
Net margin-0.3%3.4%14.4%11.7%11.5%7.9%9.5%9.5%4.5%9.5%
Free cash flow margin1.3%4.0%8.2%5.7%7.9%11.8%6.8%10.0%6.3%5.8%
Return on equity-0.3%6.3%30.6%26.3%25.5%16.2%21.5%19.9%10.7%22.2%
Return on assets-0.1%1.9%10.1%8.2%7.6%5.2%7.1%8.4%4.0%8.5%
Current ratio1.731.601.802.312.632.432.782.182.592.43
Debt to equity0.751.150.831.071.130.860.890.360.570.56

Source: XBRL data Bruker Corporation files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

Get this as JSON

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

BRKR peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
BRKR$3.51B+2.2%-$123.40M-3.5%$8.62B
TMO$47.35B+8.3%$7.07B14.9%$248.08B
A$7.37B+8.6%$1.44B19.5%$48.04B
WAT$5.61B+80.7%$98.21M1.8%$43.29B
DHR$25.61B+5.5%$4.33B16.9%$155.03B
RVTY$2.94B+4.6%$253.20M8.6%$16.21B
TECH$1.23B+0.9%$171.95M14.0%$11.42B
MTD$4.20B+6.5%$934.07M22.2%$33.15B

BRKR FAQ

9 questions
  • What is BRKR revenue?
    Bruker Corporation (BRKR) reported $3.51B of revenue for the twelve months ended Sep 30, 2026. That is up 2.2% from the year before. Revenue for fiscal 2025 was $3.44B.
  • Is BRKR profitable?
    No. Bruker Corporation reported a net loss of $123.40M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does BRKR have?
    Bruker Corporation reported $119.70M in cash and cash equivalents and $1.70B of debt on its most recent balance sheet in SEC filings.
  • How fast is BRKR revenue growing?
    Bruker Corporation's revenue changed +2.1% in fiscal 2025, to $3.44B. Its compound annual growth rate was +11.6% over 5 years and +7.8% over 10 years.
  • What is BRKR gross margin?
    Bruker Corporation's gross profit was $1.67B on $3.51B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 47.7%.
  • What is BRKR free cash flow?
    Bruker Corporation generated $244.70M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $341.80M less capital expenditures.
  • What is BRKR earnings per share?
    Diluted earnings per share were -$1.10 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did BRKR last report financial results?
    The latest statements here come from Bruker Corporation's 10-Q filed on Nov 5, 2026, covering the period ended Sep 30, 2026.
  • Where does this BRKR financial data come from?
    Quantisnow builds these statements from the structured XBRL data Bruker Corporation files with the SEC. It is provided for information only and is not investment advice.